Intelligent Bio Solutions (INBS) Gross Profit (2022 - 2025)
Intelligent Bio Solutions' quarterly Gross Profit came in at $341368.0 in Q1 2025, up 91.25% year-on-year from $178489.0 in Q1 2024, and up 53.0% quarter-over-quarter from $223113.0 in Q4 2024.
Intelligent Bio Solutions has reported Gross Profit for 4 years, with the latest figure at $341368.0 in Q1 2025.
- For the quarter ending Q1 2025, Gross Profit rose 91.25% year-over-year to $341368.0; the trailing twelve-month figure through Mar 2025 stood at $1.1 million (up 65.21% YoY), and the FY2023 full-year result was $326668.0, changed N/A from the prior year.
- Gross Profit for Q1 2025 stood at $341368.0, up from $223113.0 in the prior quarter.
- The five-year high for Gross Profit was $346801.0 in Q3 2024, with the low at $33049.0 in Q1 2023.
- Average Gross Profit over 4 years is $205335.3, with a median of $223113.0 recorded in 2024.
- Year-over-year, Gross Profit declined 18.36% in 2023 and surged 440.07% in 2024.
- Tracing INBS's Gross Profit over 4 years: stood at $244044.0 in 2022, then decreased by 18.36% to $199248.0 in 2023, then grew by 11.98% to $223113.0 in 2024, then surged by 53.0% to $341368.0 in 2025.
- The last three Gross Profit figures came in at $341368.0 (Q1 2025), $223113.0 (Q4 2024), and $346801.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 341,368.00 |
| Mar 31, 2025 | 341,368.00 |
| Dec 31, 2024 | 223,113.00 |
| Dec 31, 2024 | 223,113.00 |
| Sep 30, 2024 | 346,801.00 |
| Sep 30, 2024 | 346,801.00 |
| Mar 31, 2024 | 178,489.00 |
| Mar 31, 2024 | 178,489.00 |
| Dec 31, 2023 | 199,248.00 |
| Dec 31, 2023 | 199,248.00 |
| Sep 30, 2023 | 232,331.00 |
| Sep 30, 2023 | 232,331.00 |
| Jun 30, 2023 | 49,575.00 |
| Jun 30, 2023 | 49,575.00 |
| Mar 31, 2023 | 33,049.00 |
| Mar 31, 2023 | 33,049.00 |
| Dec 31, 2022 | 244,044.00 |
| Dec 31, 2022 | 244,044.00 |